19-38410048-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000615439.5(RASGRP4):āc.2014G>Cā(p.Asp672His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,611,742 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000615439.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RASGRP4 | NM_170604.3 | c.2014G>C | p.Asp672His | missense_variant | 17/17 | ENST00000615439.5 | NP_733749.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RASGRP4 | ENST00000615439.5 | c.2014G>C | p.Asp672His | missense_variant | 17/17 | 1 | NM_170604.3 | ENSP00000479844 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152090Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000446 AC: 11AN: 246872Hom.: 0 AF XY: 0.0000373 AC XY: 5AN XY: 134056
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1459534Hom.: 0 Cov.: 29 AF XY: 0.0000138 AC XY: 10AN XY: 726076
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152208Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74416
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 05, 2022 | The c.2014G>C (p.D672H) alteration is located in exon 17 (coding exon 17) of the RASGRP4 gene. This alteration results from a G to C substitution at nucleotide position 2014, causing the aspartic acid (D) at amino acid position 672 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at